How much is Fast Medic worth in 2026?

Fast Medic has a current valuation of N/A based on their Buyout/LBO (Add-on)† round and secondary market data.

How much funding has Fast Medic raised?

Fast Medic has raised N/A in total funding across 1 funding rounds.

Fast Medic

Enterprise Systems (Healthcare)

Fast Medic valuation and funding history | Last updated: January 12, 2026 | 1 funding rounds

Current Valuation

N/A

As of January 12, 2026

Total Funding Raised

N/A

Across 1 round

Last Round

Buyout/LBO (Add-on)†

Amount undisclosed

Last Funding

Jan 2026

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 12, 2026	Buyout/LBO (Add-on)†	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Fast Medic is currently valued at N/A as of January 12, 2026.

Track Fast Medic Valuation Updates

Get notified when Fast Medic raises new funding or valuation changes

Explore More Data

Detailed analysis for Fast Medic

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Fast Medic's valuation history, funding rounds, and growth metrics.

No credit card required

What is Fast Medic Worth in 2026?

Fast Medic is a leading private company in the Enterprise Systems (Healthcare) sector. Track Fast Medic's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Fast Medic Valuation is Determined

Private company valuations like Fast Medic's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.